The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.
about
Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.Measurement of HE4 and CA125 and establishment of reference intervals for the ROMA index in the sera of pregnant women.The fabrication of magnetic particle-based chemiluminescence immunoassay for human epididymis protein-4 detection in ovarian cancer.LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis.Increased HE4 mRNA Expression Correlates with High Level Of eIF3a mRNA And Better Survival in Women with Epithelial Ovarian Cancer.
P2860
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The role of novel biomarker HE ...... n cancer: a systematic review.
@en
type
label
The role of novel biomarker HE ...... n cancer: a systematic review.
@en
prefLabel
The role of novel biomarker HE ...... n cancer: a systematic review.
@en
P2093
P2860
P50
P1476
The role of novel biomarker HE ...... n cancer: a systematic review.
@en
P2093
Andrea Miranda
Carlo De Cicco Nardone
Corrado Terranova
Daniela Luvero
Francesco Plotti
Roberto Angioli
Stella Capriglione
P2860
P304
P356
10.1080/14737140.2017.1360138
P577
2017-07-31T00:00:00Z